Cancer biomarker -- detectable by blood test -- could improve prostate cancer detection
Monday, August 8, 2011 - 11:01
in Health & Medicine
A new study supports the use of a DNA-based "biomarker" blood test as a complement to the prostate-specific antigen (PSA) test currently offered to screen men for prostate cancer. University of Cincinnati (UC) researchers report their findings online ahead of print in the British Journal of Cancer.